These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2907828)
1. New directions in asthma: some cause for concern. Abbott A Trends Pharmacol Sci; 1988 May; 9(5):149-50. PubMed ID: 2907828 [No Abstract] [Full Text] [Related]
2. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study]. Riedl-Seifert R Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910 [No Abstract] [Full Text] [Related]
5. Asthma and hyperglycemia. Diagnosis: acute asthma exacerbation worsened by hyperglycemia. Majahan P; Kamat D Clin Pediatr (Phila); 2007 Jun; 46(5):455-7. PubMed ID: 17571320 [No Abstract] [Full Text] [Related]
6. Asthma in Arkansas: anti-inflammatory use grows, but performance still a concern. Golden WE J Ark Med Soc; 2004 Feb; 100(8):266-7. PubMed ID: 14999886 [No Abstract] [Full Text] [Related]
7. [AIRE Study: diminished quality of life is the rule in asthma. Optimally controllable, still badly controlled]. MMW Fortschr Med; 2001 Jun; 143(24):56-7. PubMed ID: 11469023 [No Abstract] [Full Text] [Related]
8. [A long-acting adrenergic beta-sympathomimetics has its place in the treatment of many asthmatic patients]. Stenius-Aarniala B Duodecim; 1999; 115(10):1081-3. PubMed ID: 11877847 [No Abstract] [Full Text] [Related]
9. NIH asthma treatment guidelines not being utilized in patient care. W V Med J; 1993 Jul; 89(7):292. PubMed ID: 8102502 [No Abstract] [Full Text] [Related]
10. Stopping long-acting beta-2 agonists. Med Lett Drugs Ther; 2010 Mar; 52(1334):21. PubMed ID: 20336032 [No Abstract] [Full Text] [Related]
11. Asthma: current controversies and emerging therapies. Kavuru MS; Pien L; Litwin D; Erzurum S; Ahmad M Cleve Clin J Med; 1995; 62(5):293-304. PubMed ID: 7586485 [TBL] [Abstract][Full Text] [Related]
12. The labyrinth of asthma therapy: lost in the choices. Kass JE; Bartter T Chest; 2000 Oct; 118(4):891-3. PubMed ID: 11035651 [No Abstract] [Full Text] [Related]
13. Inhaled beta 2-agonists and corticosteroids in the treatment of children with acute asthma attack. Volovitz B; Nussinovitch M Isr Med Assoc J; 2002 Nov; 4(11 Suppl):891-2. PubMed ID: 12455174 [No Abstract] [Full Text] [Related]
14. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Salpeter SR; Wall AJ; Buckley NS Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343 [TBL] [Abstract][Full Text] [Related]
15. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. Anderson GP Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 2):S188-96. PubMed ID: 10712373 [No Abstract] [Full Text] [Related]
16. [Next GINA report. What could be expected?]. Droszcz W Pol Merkur Lekarski; 2003 Jun; 14(84):674-5. PubMed ID: 14524301 [TBL] [Abstract][Full Text] [Related]
17. Asthma in the elderly: β-adrenergic receptor blockers may worsen, β-receptor agonists relieve (with caveats). Caviglia AG J Allergy Clin Immunol; 2011 Jun; 127(6):1639; author reply 1639. PubMed ID: 21489614 [No Abstract] [Full Text] [Related]
18. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate: comment. Ameredes BT Respirology; 2004 Nov; 9(4):570-1. PubMed ID: 15612975 [No Abstract] [Full Text] [Related]
19. Salmeterol and inhaled corticosteroids in patients with persistent asthma. Miller FG; Shorr AF JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663 [No Abstract] [Full Text] [Related]